HDAC9 and neoplasm: Overall, preclinical data showed that HDAC inhibitors potently kill DMG cells, reduce cell proliferation, and inhibit tumor growth in vitro and in animal models (Grasso et al., 2015; Anastas et al., 2019; Vitanza et al., 2021).